Samsung and MedyMatch team up to create AI medical imaging device for first aid

AsiaIndustrial NetNews: The United States has a “mobile stroke ambulance unit” ambulance, which is dedicated to the case of a stroke. NeuroLogica, a medical imaging company owned by Samsung, and MedyMatch, an Israeli artificial intelligence company, have jointly built an artificial intelligence platform for this ambulance unit with the functions of a Samsung CereTom CT scanner, making it easier for rescue physicians to use this mobile scanning tool. You can quickly tell if the patient has a cerebral hemorrhage or a blood clot.

Samsung and MedyMatch team up to create AI medical imaging device for first aid

MedyMatch’s AI diagnostic capabilities will be bundled with Samsung CereTom (Image: PR Newswire)

At the launch of Samsung’s NeuroLogica and MedyMatch, Peter Rasmussen, medical director of the Cleveland Clinic’s Telemedicine Program, said having a scanner that can quickly identify a brain hemorrhage is very important, because in this scenario, the direction of treatment is determined. There must be a race against time.

In early March 2017, MedyMatch has partnered with IBM Watson Healthcare to bring cerebral hemorrhage diagnostic applications to a larger market. The two are combining this application with IBM Watson’s imaging business.

And this integration of MedyMatch and Samsung NeroLogica is just the beginning of a “roadside AI” project. This project aims to apply the fusion of machine learning and mobile medical technology to all emergency scenarios.

“We are standing on a new threshold in medical imaging,” MedyMatch’s CEO said in the release. He said that the development of medical imaging has been focusing on clear imaging, more portable equipment, etc., and the artificial intelligence application of MedyMatch will help this trend move forward, allowing imaging instruments such as CT to provide not only images, but also medical answers. .

Numerous studies have shown that rescue strokes within the first few hours of symptoms can be effective in saving lives and reducing the impact of the condition. So there are also many health care providers experimenting with “mobile stroke units,” which move point-of-care care from the hospital to the patient’s location.

A 2015 study by the Cleveland Clinic and Cleveland Emergency Medical Services found that services like the Mobile Stroke Unit allowed patients at least 5 minutes earlier to get a CT scan and 26 minutes earlier to get clot-draining drugs.

Chicago was one of the first cities to begin testing mobile stroke ambulance units, including Northwestern Medical Center DuPage Hospital and Rush University Medical Center in Chicago, which have dispatched specially equipped ambulances for emergency use.

Harish Shownkeen, medical director of stroke and vascular care at Northwestern Medicine’s DuPage Hospital, believes that the specially equipped ambulance is a wonderful technology that will become standard in the near future. “Treatment has never changed, what has changed is the level of sophistication of the treatment tools.”

James Co, director of cerebrovascular disease at Rush University Medical CenterNners even emphasized that for stroke patients, time is really critical, because every minute of cerebral obstruction, the brain will die of about 2 million cells.

Samsung NeuroLogica CEO Phillip Sullivan said that in addition to Chicago, New York, Trenton, New Jersey, Alberta, Canada, and even Thailand, India, and Germany have “mobile CT scanning units” from Samsung NeuroLogica. “Our collaboration with Israeli artificial intelligence company MedyMatch is a step further in stroke-supporting technology.”

The Links:   3HAC10828-15 3HAC7998-2 DISPLAY

Published on 09/18/2022